Advances in the treatment of male androgenetic alopecia: current options and emerging therapies
This article examines both established and emerging therapies for AGA. We recommend initiating treatment with topical minoxidil and oral finasteride, as these are extensively researched and FDA-approved options for male AGA. For patients who do not respond well or cannot tolerate these treatments, clinicians may explore alternative therapies and approaches.
Authors
- Shruthi Polla Ravi (ORCID: https://orcid.org/0000-0001-7161-0322)
- Mesbah Talukder (ORCID: https://orcid.org/0000-0003-0691-640X)
- Daniel Taylor (ORCID: https://orcid.org/0009-0001-7721-2031)
- Tong Wang (ORCID: https://orcid.org/0000-0001-9359-9750)
- Aditya Gupta (ORCID: https://orcid.org/0000-0002-3730-8944)
Institutions
- Mediprobe Research (Canada) (CA)
- BRAC University (BD)
Publication Details
- Journal
- Italian Journal of Dermatology and Venereology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.23736/s2784-8671.25.08183-6
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00